Cbd Global Sciences Stock Current Asset
| CBDNFDelisted Stock | USD 0.06 0.00 0.00% |
CBD Global Sciences fundamentals help investors to digest information that contributes to CBD Global's financial success or failures. It also enables traders to predict the movement of CBD Pink Sheet. The fundamental analysis module provides a way to measure CBD Global's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CBD Global pink sheet.
CBD |
CBD Global Sciences Company Current Asset Analysis
CBD Global's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
CompetitionIn accordance with the recently published financial statements, CBD Global Sciences has a Current Asset of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The current asset for all United States stocks is 100.0% higher than that of the company.
CBD Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CBD Global's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CBD Global could also be used in its relative valuation, which is a method of valuing CBD Global by comparing valuation metrics of similar companies.CBD Global is currently under evaluation in current asset category among its peers.
CBD Fundamentals
| Return On Asset | -1.38 | |||
| Operating Margin | (2.71) % | |||
| Current Valuation | 14.44 M | |||
| Shares Outstanding | 49.46 M | |||
| Shares Owned By Insiders | 26.61 % | |||
| Price To Sales | 2.79 X | |||
| Revenue | 166.95 K | |||
| Gross Profit | 3.61 K | |||
| EBITDA | (4.6 M) | |||
| Net Income | (5.25 M) | |||
| Cash And Equivalents | 59.92 K | |||
| Total Debt | 1.34 M | |||
| Current Ratio | 0.09 X | |||
| Book Value Per Share | (0.26) X | |||
| Cash Flow From Operations | (1.14 M) | |||
| Earnings Per Share | (0.11) X | |||
| Beta | 0.49 | |||
| Market Capitalization | 5.93 M | |||
| Total Asset | 2.09 M | |||
| Z Score | -4.2 | |||
| Net Asset | 2.09 M |
About CBD Global Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CBD Global Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CBD Global using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CBD Global Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in CBD Pink Sheet
If you are still planning to invest in CBD Global Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CBD Global's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |